L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway

Mediators of Inflammation

Volumn 9, Issue 1, 2000, Pages 25-30

  Duarte, I D G ^a   Ferreira, S H ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

1H 1,2,4 oxadiazolo 4,3 a quinoxalin 1 one (ODQ); Carrageenin analgesia; Guanosine 3',5' monophophate cGMP; Inducible NO synthase (iNOS); Methylene blue (MB); NG monomethyl L arginine (L NMMA); NG nitro L arginine methyl ester (L NAME); Nitric oxide (NO)

Indexed keywords

1 (3 CHLOROANILINO) 4 PHENYLPHTHALAZINE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETIC ACID; ARGININE; CARRAGEENAN; CYCLIC GMP; METHYLENE BLUE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; HYPERALGESIA; MALE; NONHUMAN; PAIN; PLANTARIS MUSCLE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0034084731     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350050024348     Document Type: Article

References (32)

1. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 1991; 102: 198-202
2. 2. Babbedge RC, Hart SL, Moore PK. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA. J Pharm Pharmacol 1993; 45: 77-79.
3. 3. Roche AK, Cook M, Wilcox GL, Kajander KC. A nitric oxide synthesis inhibitor (L-NAME) reduces licking behaviour and Fos-labeling in the spinal cord of rats during formalin-induced inflammation. Pain 1996; 66: 331-341.
4. 4. Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993; 54: 291-300.
5. 5. Sakurada T, Sugiyama A, Sakurada C, et al. Effect of spinal nitric oxide inhibition on capsaicin-induced nociceptive response. Life Sci 1996; 59: 921-930.
6. 6 Yonehara N, Takemura M, Yoshimura M, et al. Nitric oxide in the rat spinal cord in Freund's adjuvant-induced hyperalgesia. Jpn J Pharmacol 1997; 75: 327-335.
7. 7. Gao WC, Qiao JT. Nitric oxide contributes to both spinal nociceptive transmission and its descending inhibition in rats: an immunocytochemical study. Neurosci Lett 1998; 240: 143-146.
8. 8. Shibuta S, Mashimo T, Zhang P, Ohara A, Yoshiya I. A new nitric oxide donor, NOC-18, exhibits a nociceptive effect in the rat formalin model. J Neurol Sci 1996; 141: 1-5.
9. 9 Duarte ID, Lorenzetti BB, Ferreira SH. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol 1990; 186: 289-293
10. 10. Duarte ID, Ferreira SH. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 1992; 221: 171-174.
11. 11. Iwamoto ET, Marion L. Pharmacological evidence that nitric oxide-mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats. J Pharmacol Exp Ther 1994; 269: 699-708.
12. 12. Xu Z, Tong C, Pan HL, Cerda SE, Eisenach JC. Intravenous morphine increases release of nitric oxide from spinal cord by an alpha adrenergic and cholinergic mechanism. J Neurophysiol 1997; 78: 2072-2078.
13. 13. Ferreira SH, Duarte ID, Lorenzetti BB. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 1991; 201: 121-122.
14. 14. Tonussi CR, Ferreira SH. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur J Pharmacol 1994; 251: 173-179.
15. 15. Granados-Soto V, Rufino MO, Gomes Lopes LD, Ferreira SH. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur J Pharmacol 1997; 340: 177-180.
16. 16. Lorenzetti BB, Ferreira SH. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm Res 1996; 45: 308-311
17. 17. Ji XQ, Zhu XZ. Possible involvement of nitric oxide in arginine-induced analgesia. Chung Kuo Yao Li Hsueh Pao 1993; 14: 289-291.
18. 18 Kumar A, Raghubir R, Srimal RC, Dhawan BN. Evidence for involvement of nitric oxide in pretectal analgesia in rat. Neuroreport 1993; 4: 706-708.
19. 19. Hentall ID. Excitation of cells in the rostral medial medulla of the rat by the nitric oxide-cyclic guanosine monophosphate messenger system. Neurosci Lett 1995; 195: 155-158.
20. 20. Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 1994; 112: 547-550.
21. 21. Miller MJ, Thompson JH, Liu X, et al. Failure of L-NAME to cause inhibition of nitric oxide synthesis: role of inducible nitric oxide synthase. Inflamm Res 1996; 45: 272-276.
22. 22. Côrrea FM, Graeff FG. Central mechanism of the hypertensive action of intraventricular bradykinin in the unanaesthetized rat. Neuropharmacol 1974; 13: 65.
23. 23. Ferreira SH, Lorenzetti BB, Correa FM. Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978; 53: 39-48.
24. 24. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990, 101: 746-752.
25. 25. Bogle RG, Moncada S, Pearson JD, Mann GE. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol 1992; 105: 768-770.
26. 26. Buxton IL, Cheek DJ, Eckman D, Westfall DP, Sanders KM, Keef KD. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 1993; 72: 387-395.
27. 27. Archer SL, Hampl V. NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. Biochem Biophys Res Commun 1992; 188: 590-596.
28. 28. Cunha FQ, Teixeira MM, Ferreira SH. Pharmacological modulation of secondary mediator systems-cyclic AMP and cyclic GMP-on inflammatory hyperalgesia. Br J Pharmacol 1999; 127: 671-678.
29. 29 Lauretti GR, Lima IC, Reis MP, Prado WA, Pereira NL. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 1999; 90: 1528-1533.
30. 30. Lauretti GR, de Oliveira R, Reis MP, Mattos AL, Pereira NL. Transdermal nitroglycerine enhances spinal sufentanil postoperative analgesia following orthopedic surgery. Anesthesiology 1999, 90: 734-739.
31. 31. Berrazueta JR, Losada A, Poveda J, et al. Successful treatment of shoulder pain syndrome due to supraspinatus tendinitis with transdermal nitroglycerin. A double blind study. Pain 1996, 66: 63-67.
32. 32. Berrazueta JR, Poveda JJ, Ochoteco J, et al. The anti-inflammatory and analgesic action of transdermal glyceryltrinitrate in the treatment of infusion-related thrombophlebitis. Postgrad Med J 1993; 69: 37-40.